NCT03976960 Clinical and Biological Database in Colon Cancer and Colic Tumors
| NCT ID | NCT03976960 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle |
| Condition | Cancer Colon |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2018-09-19 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2018-09-19 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Developement of a clinical and biological database in colon cancer and colic tumors in order to better understand tumor invasion and metastatic scattering processes. The investigators hope that a better understanding of tumoral invasion process will lead to the discovery of new biomarkers and new drugs.
Eligibility Criteria
Inclusion Criteria: 1. Patient undergoing colon cancer surgery (stage I, II, III and IV) 2. Patient operated for liver or lung or peritoneal carcinomatosis metastases originating from colon cancer 3. Patient operated for pre-neoplastic lesion (adenomatous polyp /villous adenoma polyp), 4. Patient with familial polyposis eligible for colectomy 5. Age \> 18 years 6. Signed informed consent Exclusion Criteria: 1. Patient not affiliated to Social Protection system 2. Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons 3. Patient under guardianship 4. Minor patient
Contact & Investigator
ERIC ASSENAT, M.D
STUDY CHAIR
Institut régional du cancer de Montpellier
Frequently Asked Questions
Who can join the NCT03976960 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Colon. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03976960 currently recruiting?
Yes, NCT03976960 is actively recruiting participants. Contact the research team at DRCI-icm105@icm.unicancer.fr for enrollment information.
Where is the NCT03976960 trial being conducted?
This trial is being conducted at Montpellier, France, Montpellier, France.
Who is sponsoring the NCT03976960 clinical trial?
NCT03976960 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. The principal investigator is ERIC ASSENAT, M.D at Institut régional du cancer de Montpellier. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.